AUG 11

Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies

JUL 07

Deep Longevity Published and Granted the First Microbiomic Aging Clock Patent

JUL 06

Deep Longevity Announces Latest Operational Update

JUL 05

Operational Update on the PE Prevention Drug Fortacin / Senstend - Phase 3 Study in China is Estimated to Complete in November 2022

JUN 22

Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence